Approval Agency Reforms In Asia Leave Mark On Drug Pricing – DIA Asia New Drug Development Conference
This article was originally published in PharmAsia News
Executive Summary
Drug development doesn’t happen in a bubble. Speakers at DIA’s Asia New Drug Development Conference in Tokyo urged attendees to consider the impact of unique government pricing mechanisms in the region when bringing a new product to market.